CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed
Drug / intervention
radiation therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00002480
NCT00002480Phase 1Completed
CompareCT.gov

Phase I Study of 3-Dimensional Conformal Radiotherapy in Patients With Locally Advanced (Stage T2c and T3) Adenocarcinoma of the Prostate

Memorial Sloan Kettering Cancer Center·interventional·Posted Mar 11, 2004·Updated Jun 25, 2013

In Brief

A Phase 1 clinical trial evaluating radiation therapy for Prostate Cancer. Completed, across 1 site.

Detailed Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Radiation therapy may be an effective treatment for prostate cancer. PURPOSE: Phase I trial to study the effectiveness of radiation therapy in treating patients who have stage II or stage III prostate cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 11, 2004
Enrollment StartFeb 1, 1991
Primary CompletionAug 1, 2005
TodayJul 2, 2026
Enrollment to primary: 14.5 yearsPosted 22.3 years ago

Interventions

radiation therapyradiation